Geode Capital Management »

Acrivon Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.8M 190k 9.56
2023-06-30 $2.3M 179k 12.96
2023-03-31 $2.2M 175k 12.69